Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Carl Zeiss Meditec (1AFX) Stock Price & Analysis

0 Followers

1AFX Stock Chart & Stats

€34.60€0.02(0.06%)
At close: 5:30 PM GMT+1
€30€32.5€35Aug 17Aug 31Sep 14Sep 29Oct 12Oct 26Nov 10
Day’s Range
EUR 33.94 - EUR 35.68
52-Week Range
EUR 17.00 - EUR 66.40
Previous Close
EUR 34.58
Volume
N/A
Average Volume (3M)
266
Market Cap
EUR 3.08B
Enterprise Value
EUR 2.72B
Total Cash (Recent Filing)
EUR 23.90M
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
20.6
Beta
0.96
Next Earnings
Dec 10, 2026 (Est.)
EPS Estimate
0.46
Next Dividend Ex-Date
N/A
Dividend Yield
1.58%

Bulls Say, Bears Say

Bulls Say

Diversified Medical Technology Portfolio

Carl Zeiss Meditec serves several important ophthalmic and microsurgical workflows rather than relying on a single device category. This breadth can support cross-selling, deepen customer relationships, and provide a more durable platform for growth as clinical needs and procedure volumes evolve.

Strong Gross Margin And Historical Growth

A strong gross margin indicates that the company has maintained meaningful economic value in its products and managed direct costs effectively. Combined with a history of revenue growth, this provides a foundation for reinvestment in product development, sales coverage, and customer support.

Healthy Balance Sheet

Low leverage and substantial equity funding give Carl Zeiss Meditec financial resilience through changes in demand and operating performance. This balance-sheet strength can preserve strategic flexibility, support continued investment, and reduce dependence on external financing during weaker periods.

Bears Say

Recent Revenue Contraction

The reported revenue contraction indicates that recent demand or execution has not matched the company’s longer-term growth profile. If weakness persists, it could reduce operating leverage, slow expansion of the installed base, and limit the resources available for innovation and commercial investment.

Profitability Margin Pressure

Declining net profit, EBIT, and EBITDA margins show that revenue is translating into less operating and bottom-line profit. Persistent margin pressure could weaken earnings durability, constrain internal funding for growth, and require operational improvements before financial performance can regain momentum.

Weaker Free Cash Flow Conversion

Positive operating cash flow is supportive, but weaker free cash flow growth and conversion indicate less cash is being retained after investment needs. Continued deterioration could reduce funding flexibility for product development, acquisitions, upgrades, or shareholder returns.

Carl Zeiss Meditec News

1AFX FAQ

What was Carl Zeiss Meditec’s price range in the past 12 months?
Carl Zeiss Meditec lowest stock price was €17.00 and its highest was €66.40 in the past 12 months.
What is Carl Zeiss Meditec’s market cap?
Carl Zeiss Meditec’s market cap is €3.08B.
When is Carl Zeiss Meditec’s upcoming earnings report date?
Carl Zeiss Meditec’s next earnings report is estimated for Dec 10, 2026 (not yet confirmed), which is in 27 days.
How were Carl Zeiss Meditec’s earnings last quarter?
Carl Zeiss Meditec released its earnings results on Aug 06, 2026. The company reported €0.54 earnings per share for the quarter, beating the consensus estimate of €0.41 by €0.13.
Is Carl Zeiss Meditec overvalued?
According to Wall Street analysts Carl Zeiss Meditec’s price is currently Overvalued.
Does Carl Zeiss Meditec pay dividends?
Carl Zeiss Meditec does not currently pay dividends.
What is Carl Zeiss Meditec’s EPS estimate?
Carl Zeiss Meditec’s EPS estimate is 0.46.
How many shares outstanding does Carl Zeiss Meditec have?
Carl Zeiss Meditec has 89,440,570 shares outstanding.
What happened to Carl Zeiss Meditec’s price movement after its last earnings report?
Carl Zeiss Meditec reported an EPS of €0.54 in its last earnings report, beating expectations of €0.41. Following the earnings report the stock price went down -3.074%.
Which hedge fund is a major shareholder of Carl Zeiss Meditec?
Currently, no hedge funds are holding shares in IT:1AFX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology